Article

Time-Limited Therapy With Belatacept in Kidney Transplant Recipients

2022-04-07

Abstract excerpt

In kidney transplant recipients, belatacept is usually pursued indefinitely after it has been started. In the setting of the belatacept shortage and after having evaluated the benefit-risk ratio, we established a strategy consisting of time-limited belatacept therapy / transient calcineurin inhibitor withdrawal, whose results are analyzed in that study. We considered all the kidney transplant recipients that had b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3b73fc5f-971c-504e-b1b6-cf8f4864c602
DOI: 10.20944/preprints202204.0060.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Time-Limited Therapy With Belatacept in Kidney Transplant RecipientsDOI 10.20944/preprints202204.0060.v1Read

Prevention of acute rejection after rescue with Belatacept by association of low-dose Tacrolimus maintenance in medically complex kidney transplant recipients with early or late graft dysfunction.Semantic proximity Read

Rationale and criteria of eligibility for calcineurin inhibitor interruption following kidney transplantation.Semantic proximity Read

Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapySemantic proximity Read

Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal samplesSemantic proximity Read

CD28-Selective Inhibition Prolongs Non-Human Primate Kidney Transplant SurvivalSemantic proximity Read

Breakthrough Covid-19 cases despite tixagevimab and cilgavimab (Evusheld™) prophylaxis in kidney transplant recipientsSemantic proximity Read

Contrasting CD25hiCD4+T Cells/FOXP3 Patterns in Chronic Rejection and Operational Drug-Free ToleranceSemantic proximity Read

Assessing Relative Risks of Infection and Rejection: A Meta-analysis using an Immune Function AssaySemantic proximity Read

Ex vivo expansion of regulatory T cells from long-term Belatacept-treated kidney transplant patients restores their phenotype and suppressive function but not their FOXP3 TSDR demethylation status.Semantic proximity Read

Challenge for long-term discontinuation of immunosuppressants in children with idiopathic nephrotic syndrome: a single-center experience over 10 yearsSemantic proximity Read

BKV Clearance Time Correlates With Exhaustion State and T-Cell Receptor Repertoire Shape of BKV-Specific T-Cells in Renal Transplant PatientsSemantic proximity Read

What is New in Prophylaxis and Treatment of Covid- 19 in Renal Transplant Patients?Semantic proximity Read